At the meeting held on 17 November 2021, The Royal Pharmaceutical Society Assembly members agreed a number of amendments to the Society’s regulations to clarify distinctions between Pharmaceutical Press and Pharmaceutical Press Ltd, and other aspects of PhP governance.
The relevant amended regulations are provided here along with an outline summary of the rationale for the change. The amended Regulations will take effect from 1 February 2022.
Any member who wishes to comment to the Assembly on the changes is asked to do so by 21 January 2022. Comments should be emailed to: president@rpharms.com
Last updated